Effect of immunosuppression on cytotoxic activity in amyotrophic lateral sclerosis.
Conradi
S
S
Department of Clinical Neurology, Karolinska sjukhuset, Stockholm, Sweden.
Ronnevi
L O
LO
D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000276:immunology* / Q000628:therapy; D001379:Azathioprine / Q000494:pharmacology* / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000494:pharmacology* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone